Fig. 4From: Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLDTriglyceride (TG) levels in HepG2 fatty liver cells (n = 3)Back to article page